Ebrantil and Exforge hct drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ebrantil (urapidil) and Exforge hct (amlodipine; hydrochlorothiazide; valsartan). Common drug interactions include blood pressure decreased among females and bladder hypertrophy among males.

The phase IV clinical study analyzes what interactions people have when they take Ebrantil and Exforge hct. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Ebrantil?

Ebrantil has active ingredients of urapidil. eHealthMe is studying from 1,656 Ebrantil users. Check the latest studies of Ebrantil.

What is Exforge hct?

Exforge hct has active ingredients of amlodipine; hydrochlorothiazide; valsartan. It is often used in high blood pressure. eHealthMe is studying from 4,095 Exforge hct users. Check the latest studies of Exforge hct.



On Jul, 09, 2026

22 people who take Ebrantil and Exforge hct together, and have interactions are studied.

Ebrantil and Exforge hct drug interactions.

What are the common drug interactions of Ebrantil and Exforge Hct, by gender? *:

female:

  1. Blood pressure decreased
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Renal failure acute (rapid kidney dysfunction)
  4. Arthralgia (joint pain)
  5. Blood pressure systolic increased
  6. Fatigue (feeling of tiredness)
  7. Hypotension (abnormally low blood pressure)
  8. Lyme disease (a bacterial infection that is spread to humans by infected ticks)
  9. Sleep disorder
  10. Urine output decreased

male:

  1. Bladder hypertrophy (bladder overgrowth- increase in cell size)
  2. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Inflammation
  5. Pleural effusion (water on the lungs)
  6. Pulmonary congestion (congestion in the lungs)
  7. Speech disorder
  8. Ventricular hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do)
  9. Bladder dysfunction
  10. Renal failure acute (rapid kidney dysfunction)

What are the common drug interactions of Ebrantil and Exforge Hct, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Urine output decreased
  2. Bladder hypertrophy (bladder overgrowth- increase in cell size)
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Inflammation
  5. Pleural effusion (water on the lungs)
  6. Pulmonary congestion (congestion in the lungs)
  7. Speech disorder
  8. Ventricular hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do)
  9. Bladder dysfunction
  10. Renal failure acute (rapid kidney dysfunction)

What are the existing conditions these people have? *

  1. Pain: 6 people, 27.27%
  2. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 6 people, 27.27%
  3. Acute Kidney Failure: 6 people, 27.27%
  4. Oesophagitis (inflammation of oesophagus): 5 people, 22.73%
  5. Metabolic Disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues): 5 people, 22.73%
  6. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 2 people, 9.09%
  7. Oedema Peripheral (superficial swelling): 2 people, 9.09%
  8. Lipid Metabolism Disorder (genetic disorders are caused by errors in fatty acid metabolism): 2 people, 9.09%
  9. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 9.09%
  10. Anaemia (lack of blood): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Ebrantil and Exforge hct?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ebrantil and Exforge hct:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ebrantil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Exforge hct:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ebrantil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Exforge hct and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on urapidil and amlodipine; hydrochlorothiazide; valsartan (the active ingredients of Ebrantil and Exforge hct, respectively), and Ebrantil and Exforge hct (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: